Article

pubs.acs.org/joc

Rh(III)-Catalyzed Oxidative Annulation of 2‑Phenylimidazo[1,2‑a]pyridines
with Alkynes: Mono versus Double C−H Activation
Zisong Qi, Songjie Yu, and Xingwei Li*
Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China

*S Supporting Information

ABSTRACT: Rh(III)-catalyzed C−H activation of 2-phenylimidazo[1,2-a]pyridines in divergent oxidative coupling with
alkynes has been achieved. Selective mono versus 2-fold C−H activation has been attained under condition control. When
AgOAc was used as an oxidant, the coupling aﬀorded 5,6-disubstituted naphtho[1′,2′:4,5]imidazo[1,2-a]pyridines as a result of
initial nitrogen chelation-assisted C−H activation at the benzene ring followed by rollover C−H activation. In contrast, the
reaction aﬀorded a fused isoquinolinium salt as a result of C−C and C−N coupling when AgBF4 was employed as a co-oxidant. A
rhodacyclic intermediate has been isolated.

■ INTRODUCTION
Arenes and heteroarenes with extended conjugated π-systems
have received considerable attention owing to their potential
utility as organic electronic materials.1 Therefore, many future
applications require the improvement of existing synthetic
methods for extended π-systems. Transition metal-catalyzed
C−H bond activation has received increasing attention as a
powerful strategy in synthetic chemistry in the past decades.2 In
particular, Rh(III)-catalyzed functionalization of C(aryl)−H
bonds has experienced tremendous progress owing to their
high eﬃciency, broad scope, and high functional group
tolerance.3 Signiﬁcantly, preparation of heterocycles via
rhodium(III)-catalyzed C−H activation of arenes and oxidative
coupling with alkynes has been established as an important
method by many research groups.4 The group of Miura and
Satoh demonstrated the rhodium(III)-catalyzed synthesis of
polyarylated naphthyl-/anthrylazole,5 acene,6 indolo[2,1-a]-
isoquinoline,7 and naphthothiophene derivatives.8 Cramer and
co-workers reported the synthesis of anthracenes via oxidative
annulations of naphthalenes.9 Very recently, Rh(III)-catalyzed
syntheses of aza-fused polycyclic quinolines,10
eﬃcient
naphthapyrans,11 phenanthroimidazoles,12 and naphthyridines13
have also been described. Hua and co-workers reported synthesis
of multisubstituted 2-aminoquinolines via Rh(III)-catalyzed
coupling between tetrazoles and internal alkynes.14
As a continuation of our interest in Rh(III)-catalyzed double
C−H activation of arenes,15 we aim to explore the synthesis of
fused heteroaromatics through double C−H bond activation
resulting in oxidative annulations. We reasoned that
the
coupling of 2-phenylimidazo[1,2-a]pyridines with alkynes may

follow this reaction pattern. This is because,
in addition to
chelation-assisted C−H activation in the benzene ring, the
3-position of this heterocycle is also very reactive. Thus, the
expected 2-fold C−H activation process may involve either
N-chelation-assisted C−H activation followed by subsequent
rollover C−H bond activation16 or C(3)-chelation-assisted cyclo-
metalation. We now report a convenient condition-controlled
approach to access 5,6-disubstituted naphtho[1′,2′:4,5]imidazo-
[1,2-a]pyridines and a fused isoquinolinium via rhodium(III)-
catalyzed C−H activation of 2-phenylimidazo[1,2-a]pyridines.
■ RESULTS AND DISSCUSSION
<para sub=“opt”>
The coupling of 2-phenylimidazo[1,2-a]pyridine (1a) with
diphenylacetylene (2a) was selected as a model reaction for the
screening of the reaction parameters (Table 1). The initial reac-
tion of 1a with 2a was carried out in the presence of 4 mol % of
[RhCp*Cl2]2 (Cp* = 1,2,3,4,5-pentamethylcyclopentadienyl)
and 16 mol % of AgSbF6 as the catalyst at 100 °C in DCE.
While no product was detected when Ag2CO3 was used as an
oxidant (Table 1, entry 1), switching the oxidant to AgOAc and
Cu(OAc)2 resulted in the isolation of the desired product 3aa
in 87% and 44% yield, respectively (entries 2 and 3), as a result
of formal 2-fold C−H activation. Further examination of the
solvent revealed that 1,4-dioxane, toluene, THF, and EtOAc all
gave inferior results (entries 4−7). In a control experiment,
omitting AgSbF6 led to the product 3aa in a low yield (entry 8)
and no reaction was observed when neither AgSbF6 nor
</para>
Received:
January 9, 2015
Published: March 13, 2015

© 2015 American Chemical Society

3471

DOI: 10.1021/acs.joc.5b00059
J. Org. Chem. 2015, 80, 3471−3479

The Journal of Organic Chemistry
Table 1. Optimization Studiesa

entry

catalyst

1
2
3
4
5
6
7
8
9

[RhCp*Cl2]2/AgSbF6
[RhCp*Cl2]2/AgSbF6
[RhCp*Cl2]2/AgSbF6
[RhCp*Cl2]2/AgSbF6
[RhCp*Cl2]2/AgSbF6
[RhCp*Cl2]2/AgSbF6
[RhCp*Cl2]2/AgSbF6
[RhCp*Cl2]2
−

oxidant
Ag2CO3
AgOAc
Cu(OAc)2
AgOAc
AgOAc
AgOAc
AgOAc
AgOAc
AgOAc

solvent

yield (%)b

DCE
DCE
DCE
1,4-dioxane
toluene
THF
EtOAc
DCE
DCE

nd
87
44
56
38
42
35
75
nd

aReaction conditions: [RhCp*Cl2]2 (4 mol %), AgSbF6 (16 mol %),
oxidant (2.2 equiv), 1a (0.20 mmol), and 2a (0.24 mmol) in solvent
(2 mL) at 100 °C for 12 h. bYield of isolated product.
<para sub=“opt”>
[RhCp*Cl2]2 was used (entry 9). Thus,
the following
conditions were eventually chosen for subsequent studies:
[RhCp*Cl2]2 (4 mol %), AgSbF6 (16 mol %), AgOAc (2.2
equiv) in DCE (2 mL) at 100 °C for 12 h.
</para>
<para sub="scope">
Under the standard reaction conditions, we ﬁrst examined
the 2-arylimidazo[1,2-a]pyridine substrates
the scope of
(1a−y) in the coupling with diphenylacetylene (2a) (Scheme 1).
2-Arylimidazo[1,2-a]pyridines bearing electron-donating, electron-
withdrawing, and halogen groups at the para position of benzene
ring were generally well-tolerated and aﬀorded products
3aa−ha in moderate to good isolated yields. Moreover, a
larger-scale (5 mmol) synthesis of 3aa resulted in somewhat
lower isolation (60%). An exception was observed for the
substrate bearing a p-nitro group, where only low isolated yield
was obtained (3ia). It was observed that substrate bearing a
m-chloro group underwent selective C−H activation at the less
hindered site to aﬀord the desired product 3ja in 83% yield.
However, the m-methoxy-substituted substrate aﬀorded two
regioisomeric products that could be chromatographically
separated (3ka and 3k′a), and the identity of 3k′a has been
conﬁrmed by X-ray crystallography.17 The desired products
were isolated in 70−80% yield when a methyl or halogen group
was introduced to the imidazo[1,2-a]pyridine ring (3la−oa).
Substrates bearing methyl, methoxy, halo, and even cyano on
both the benzene and pyridine ring also reacted smoothly to
aﬀord products in good yields (3pa−wa). However,
the
8-methyl-substituted substrate exhibited lower reactivity and
formed 3xa in 39% yield, implying that the reaction is strongly
aﬀected by the steric eﬀect at this position and that the C−H
activation might be assisted by N-coordination. Importantly,
the arene ring in the substrate is not limited to a benzene sys-
tem. When 2-(thiophen-2-yl)imidazo[1,2-a]pyridine was em-
ployed under the standard conditions, product 3ya was isolated
in 93% yield.
</para>
<para sub="scope">
We next explored the scope and limitations of alkyne sub-
strate in this coupling (Scheme 2). Symmetric diarylacetylenes
bearing various substituents such as methyl, methoxy, halogen,
and triﬂuoromethyl at the 4-position all coupled smoothly with
1a in 67−89% yields (3ab−af). Diarylacetylene bearing a
m-methyl provided 3ag in low yield, and two rotational isomers
were observed as indicated by 1H and 13C NMR spectroscopy.
This reaction is also compatible with o-ﬂuoro-substituted
diarylacetylene, from which product 3ah was isolated in 43% yield.
</para>
Article
<para sub="scope">
The annulative coupling between bis(2-thiophenyl)acetylene
and 1a took place to aﬀord 3ai in only 33% yield, indicative of
limitation of
the alkyne. It should be noted that diethyl
acetylenedicarboxylate displayed good reactivity and aﬀorded
product 3aj
in 85% yield. Unsymmetrical alkynes such as
1-phenyl-1-propyne were also applicable. Although the eﬃciency
of this reaction is limited (3ak, 33%), the regioselectivity with
to alkyne insertion is high. Aside from 2k, other
respect
unsymmetrical diarylacetylenes or alkyl phenylpropiolate also
coupled with 1a in high eﬃciency, but a mixture of two
regioisomeric products was isolated in approximately 2:1 ratio
(3al and 3al′, 3am and 3am′, 3an and 3an′), and they failed to
be chromatographically separated. All the above results seem to
indicate that more electron-poor alkynes are more reactive. In
contrast, both 3-hexyne and phenylacetylene failed to undergo
the desired reaction.
</para>
<para sub="scope">
To further extend the usage of the arene substrates and
encouraged by the reports by Cheng,18 You,19 and others,20 we
applied the imidazo[1,2-a]pyridines to an alternative oxidative
C−C/C−N coupling reaction. Thus, 1a and 2a were treated
under modiﬁed conditions reported by You, and the reaction
aﬀorded a fused isoquinolinium 4a in 88% yield. The scope of
the arenes and alkynes was next brieﬂy explored (Scheme 3). It
was found that substrates bearing methyl, methoxy, and chloro
groups were fully tolerated in this transformation, and the salt
products were isolated in consistently good to high yields (4a−f).
</para>
<para sub=“props”>
these
products, we measured the absorption and emission spectra of a
few products in CH2Cl2. 3aa, 3ca, and 3ya showed strong
absorption bands between 240 and 300 nm and showed strong
emissions of violet
light between 410 and 480 nm when
irradiated by light at 260 nm wavelength. In contrast, 3ia only
showed relatively weak emissions at 393 and 618 nm when
irradiated by light of 310 nm wavelength (see Supporting
Information).

To further understand the physical properties of
</para>
<para sub="scope">
Several experiments have been performed to investigate the
reaction mechanism. A competitive reaction has been
conducted using an equimolar mixture of 1a and 2-([D5]-
phenyl)imidazo[1,2-a]pyridine (1a-d5) in the coupling with 2a.
1H NMR spectroscopic analysis of the product mixture revealed
a kinetic isotope eﬀect (KIE) of 1.9 at a low conversion (eq 1).
A stoichiometric reaction between 1a and [RhCp*Cl2]2 was
performed in the presence of NaOAc,
from which the
cyclometalated product 5 was isolated in 74% yield. Complex
</para>
3472

DOI: 10.1021/acs.joc.5b00059
J. Org. Chem. 2015, 80, 3471−3479

The Journal of Organic Chemistry
Scheme 1. Substrate Scope of 2-Phenylimidazo[1,2-a]pyridinesa

Article

aReaction conditions: [RhCp*Cl2]2 (4 mol %), AgSbF6 (16 mol %), AgOAc (2.2 equiv), 1 (0.20 mmol), and 2a (0.24 mmol) in DCE (2 mL)
at 100 °C for 12 h. Yield of isolated product.
<para sub="scope">
5 has been fully characterized by 1H and 13C NMR spec-
troscopy. In particular, the Rh−C resonates as a doublet at δ
174.4 (JRh−C = 31.2 Hz) in the 13C NMR spectrum (100 MHz,
CDCl3). Complex 5 proved to be an active catalyst because
when it was designated as a catalyst (7 mol %) in the presence
of AgSbF6 for the coupling between 1a and 2a, product 3aa was
isolated in a comparable yield (eq 3). In addition to this
coupling reaction, 5 also proved to be an active catalyst for the
C−C/C−N coupling between 1a and 2a to aﬀord 4a in 82%
yield. These results indicated that in both coupling systems, the
C−H activation is initially assisted by N-coordination, and in
the formation of 3aa, subsequent rollover C−H activation16 to the
C(3) position of the heterocycle is likely involved (see Scheme 4).
</para>
<para sub="scope">
Based on these observations and literature precedents,16a,19 a
proposed reaction mechanism is given in Scheme 4. First, coordina-
tion of 1a to rhodium and subsequent cyclometalation generates
rhodacyclic intermediate 5. Insertion of an incoming alkyne gives
seven-membered rhodacycle 6. This intermediate is proposed to
undergo nitrogen decoordination and rollover C−H activation16 to
aﬀord intermediate 7, which is proposed to undergo reductive
elimination to aﬀord product 3aa and a Rh(I) species. The Rh(I) is
reoxidized by AgOAc to regenerate the rhodium(III) active catalyst
for the next catalytic cycle. Alternatively, C−N bond reductive
elimination of the rhodacycle 6 followed by anion exchange gives
the fused isoquinolinium salt 4a and a Rh(I) species, which was
oxidized by Cu(OAc)2 to regenerate the Rh(III) active catalyst.
</para>
3473

DOI: 10.1021/acs.joc.5b00059
J. Org. Chem. 2015, 80, 3471−3479

The Journal of Organic Chemistry
Scheme 2. Scope of the Alkyne Substratea

Article

Scheme 3. Synthesis of Fused Isoquinolinium
Tetraﬂuoroboratesa

aReaction conditions: [RhCp*Cl2]2 (4 mol %), AgBF4 (1.0 equiv),
Cu(OAc)2 (1.0 equiv), 1 (0.20 mmol), and 2 (0.20 mmol) in DCE
(3 mL) at 100 °C for 24 h. Yield of isolated product.

■ CONCLUSION
We have developed Rh(III)-catalyzed divergent C−H activation
of 2-phenylimidazo[1,2-a]pyridines in the oxidative coupling with
alkynes. Selective mono versus 2-fold C−H activation has been
attained under condition control. When AgOAc was used as an
oxidant,
this coupling aﬀorded 5,6-disubstituted naphtho-
[1′,2′:4,5]imidazo[1,2-a]pyridines as a result of inititial chelation-
assisted C−H activation at the benzene ring followed by rollover
C−H activation at the heterocycle. In contrast, the reaction
aﬀorded a fused isoquinolinium as a result of C−C and C−N
coupling while AgBF4 was employed as a co-oxidant. In both
the initial C−H activation is assisted by nitrogen
cases,
coordination. A rhodacyle complex has been isolated and has
been established as a reactive intermediate. This work expanded
the scope of rhodium-catalyzed C−H activation of arenes for
the synthesis of extended π-systems.
■ EXPERIMENTAL SECTION

General
<para sub=“exp”>
Information. All chemicals were obtained from
commercial sources and were used as received unless otherwise
noted. Diarylacetylenes21 other
than diphenylacetylene and 2-
phenylimidazo[1,2-a]pyridines22 were prepared by following literature
</para>
3474

DOI: 10.1021/acs.joc.5b00059
J. Org. Chem. 2015, 80, 3471−3479

The Journal of Organic Chemistry

Scheme 4. Proposed Reaction Mechanism
<para sub=“exp”>
reports. [RhCp*Cl2]2 was prepared from RhCl3
·xH2O according to a
literature procedure.23 All reactions were carried out using Schlenk
techniques or
in a nitrogen-ﬁlled glovebox. NMR spectra were
recorded on a 400 MHz NMR spectrometer in the solvent indicated.
The chemical shift is given in dimensionless δ values and is frequency
referenced relative to TMS in 1H and 13C NMR spectroscopy. HRMS
data were obtained via ESI mode with a TOF mass analyzer. Column
chromatography was performed on silica gel (300−400 mesh) using
ethyl acetate (EA)/petroleum ether (PE) or MeOH/CH2Cl2.
General Procedures for Synthesis of 3. 2-Phenylimidazo[1,2-a]-
pyridines (0.20 mmol), alkynes (0.24 mmol), [RhCp*Cl2]2 (4 mol %),
AgSbF6 (16 mol %), AgOAc (2.2 equiv), and DCE (2 mL) were
charged into the sealed tube. The reaction mixture was stirred at
100 °C for 12 h. After cooling to room temperature, the solvent was
removed under reduced pressure and the residue was puriﬁed by silica
gel chromatography using PE/EA to aﬀord the desired product 3.
5,6-Diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine (3aa).
white solid (64.4 mg, 87%); mp 299−300 °C; 1H NMR (400 MHz,
CDCl3) δ 8.98 (d, J = 8.1 Hz, 1H), 7.84 (d, J = 9.0 Hz, 1H), 7.70 (ddd,
J = 8.1, 6.9, 1.0 Hz, 1H), 7.61 (d, J = 8.3 Hz, 1H), 7.49 (ddd, J = 8.3,
6.9, 1.3 Hz, 1H), 7.35−7.17 (m, 12H), 6.48 (td, J = 7.0, 1.1 Hz, 1H);
13C NMR (100 MHz, CDCl3) δ 148.2, 141.1, 138.8, 137.1, 133.7,
131.8, 131.7, 130.6, 128.7, 127.9, 127.8, 127.7, 127.4, 126.80, 126.77,
126.7, 126.4, 126.34, 126.32, 123.2, 122.8, 118.0, 110.8; HRMS:
[M + H]+ calculated for C27H19N2: 371.1543, found 371.1542.
3-Methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ba). white solid (56.1 mg, 73%); mp 292−293 °C; 1H NMR
(400 MHz, CDCl3) δ 8.87 (d, J = 8.3 Hz, 1H), 7.81 (d, J = 9.0 Hz,
1H), 7.54 (dd, J = 8.3, 1.2 Hz, 1H), 7.37 (s, 1H), 7.34−7.16 (m, 12H),
6.46 (td, J = 7.0, 1.0 Hz, 1H), 2.44 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 148.2, 141.2, 138.9, 137.3, 136.1, 133.3, 131.82, 131.81,
130.6, 128.6, 128.4, 127.8, 127.7, 127.2, 127.0, 126.8, 126.7, 126.6,
124.3, 123.1, 122.4, 117.9, 110.6, 22.2; HRMS: [M + H]+ calculated
for C28H21N2: 385.1699, found 385.1703.
3-Methoxy-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ca). pale yellow solid (56.1 mg, 70%); mp 244−246 °C; 1H NMR
(400 MHz, CDCl3) δ 8.88 (d, J = 8.9 Hz, 1H), 7.79 (d, J = 9.1 Hz,
1H), 7.36 (dd, J = 8.9, 2.5 Hz, 1H), 7.33−7.15 (m, 12H), 6.96 (d, J =
2.5 Hz, 1H), 6.45 (td, J = 7.0, 1.1 Hz, 1H), 3.71 (s, 3H); 13C NMR
(100 MHz, CDCl3) δ 158.2, 148.3, 141.3, 138.9, 137.2, 133.1, 132.8,
131.7, 130.5, 128.6, 127.8, 127.8, 127.3, 127.2, 126.8, 126.6, 124.7,
121.8, 121.1, 117.8, 117.1, 110.6, 108.3, 55.3; HRMS: [M + H]+
calculated for C28H21N2O: 401.1648, found 401.1650.
3-Fluoro-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3da). pale yellow solid (53.5 mg, 69%); mp 279−280 °C; 1H NMR
(400 MHz, CDCl3) δ 8.96 (dd, J = 8.9, 5.9 Hz, 1H), 7.82 (d, J = 9.1 Hz,
</para>
Article
<para sub=“exp”>
1H), 7.44 (td, J = 8.6, 2.5 Hz, 1H), 7.37−7.20 (m, 11H), 7.18−7.15
(m, 2H), 6.50 (dd, J = 10.0, 3.7 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ 161.4 (d, J = 242.7 Hz), 148.4, 141.2, 138.3, 136.9, 133.1 (d,
J = 7.5 Hz), 133.0 (d, J = 3.3 Hz), 131.6, 130.4, 128.7, 128.04, 127.99,
127.91, 127.6, 127.0, 126.7, 125.5 (d, J = 9.1 Hz), 123.1, 122.5, 118.0,
115.8 (d, J = 24.5 Hz), 111.9 (d, J = 22.3 Hz), 110.9; HRMS:
[M + H]+ calculated for C27H18FN2: 389.1449, found 389.1447.
3-Chloro-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ea). white solid (65.5 mg, 81%); mp 300−301 °C; 1H NMR (400
MHz, CDCl3) δ 8.90 (d, J = 8.7 Hz, 1H), 7.82 (d, J = 9.2 Hz, 1H),
7.64 (dd, J = 8.7, 2.0 Hz, 1H), 7.58 (d, J = 2.0 Hz, 1H), 7.38−7.29 (m,
4H), 7.29−7.20 (m, 6H), 7.19−7.13 (m, 2H), 6.50 (td, J = 7.0, 1.1 Hz,
1H); 13C NMR (100 MHz, CDCl3) δ 148.5, 141.0, 138.0, 136.8,
132.9, 132.7, 132.4, 131.7, 130.4, 128.8, 128.1, 128.0, 127.9, 127.8,
127.1, 127.0, 126.8, 126.7, 124.8, 124.6, 123.0, 118.0, 111.0; HRMS:
[M + H]+ calculated for C27H18ClN2: 405.1153, found 405.1154.
3-Bromo-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3fa). pale yellow solid (63.7 mg, 71%); mp 302−303 °C; 1H NMR
(400 MHz, CDCl3) δ 8.83 (d, J = 8.6 Hz, 1H), 7.92−7.68 (m, 3H),
7.43−7.10 (m, 12H), 6.51 (t, J = 6.4 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ 148.5, 141.0, 138.0, 136.7, 133.0, 132.8, 131.7, 130.4,
129.9, 129.6, 128.8, 128.1, 128.0, 127.9, 127.8, 127.1, 126.7, 125.0,
124.8, 123.0, 120.8, 118.1, 111.0; HRMS: [M + H]+ calculated for
C27H18BrN2: 449.0648, found 449.0644.
3,5,6-Triphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine (3ga).
white solid (49.9 mg, 56%); mp >300 °C; 1H NMR (400 MHz,
CDCl3) δ 9.04 (d, J = 8.5 Hz, 1H), 7.98 (dd, J = 8.5, 1.7 Hz, 1H),
7.90−7.81 (m, 2H), 7.61−7.54 (m, 2H), 7.43−7.37 (m, 2H), 7.36−
7.19 (m, 13H), 6.50 (td, J = 6.9, 1.0 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ 148.4, 141.7, 139.1, 138.7, 137.2, 134.1, 132.0, 131.8, 130.6,
128.9, 128.7, 127.9, 127.8, 127.7, 127.5, 127.33, 127.29, 126.9, 126.7,
125.98, 125.95, 125.4, 123.8, 118.1, 110.8. Two carbons are not visible
due to overlapping peaks; HRMS: [M + H]+ calculated for C33H23N2:
447.1856, found 447.1856.
5,6-Diphenyl-3-(triﬂuoromethyl)naphtho[1′,2′:4,5]imidazo[1,2-
a]pyridine (3ha). white solid (59.6 mg, 68%); mp 261−262 °C; 1H
NMR (400 MHz, CDCl3) δ 9.07 (d, J = 8.5 Hz, 1H), 7.92 (s, 1H),
7.88 (dd, J = 8.6, 1.3 Hz, 1H), 7.84 (d, J = 9.2 Hz, 1H), 7.38−7.21 (m,
10H), 7.20−7.14 (m, 2H), 6.51 (td, J = 7.1, 1.0 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 148.6, 140.6, 137.7, 136.6, 134.1, 131.7, 130.8,
130.4, 128.8, 128.3, 128.23, 128.18, 128.0, 127.94, 127.89, 127.3,
126.7, 125.2 (q, J = 4.5 Hz), 124.7 (q, J = 270.6 Hz), 124.2, 123.9,
122.0 (q, J = 3.2 Hz), 118.2, 111.2; HRMS: [M + H]+ calculated for
C28H18F3N2: 439.1417, found 439.1418.
3-Nitro-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ia). yellow solid (25.0 mg, 30%); mp >300 °C; 1H NMR (400 MHz,
CDCl3) δ 9.07 (d, J = 9.0 Hz, 1H), 8.56 (d, J = 2.1 Hz, 1H), 8.44 (dd,
J = 9.0, 2.2 Hz, 1H), 7.86 (d, J = 9.2 Hz, 1H), 7.43−7.35 (m, 4H),
7.33−7.23 (m, 6H), 7.23−7.17 (m, 2H), 6.57 (t, J = 6.5 Hz, 1H); 13C
NMR (100 MHz, CDCl3) δ 149.0, 146.1, 140.5, 137.2, 136.2, 134.9,
131.7, 130.8, 130.3, 129.4, 129.1, 129.0, 128.5, 128.4, 128.1, 127.6,
126.8, 124.9, 124.7, 124.4, 119.9, 118.4, 111.6; HRMS: [M + H]+
calculated for C27H18N3O2: 416.1394, found 416.1395.
2-Chloro-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ja). pale white solid (67.1 mg, 83%); mp 277−278 °C; 1H NMR
(400 MHz, CDCl3) δ 8.93 (d, J = 1.9 Hz, 1H), 7.78 (d, J = 9.1 Hz,
1H), 7.51 (d, J = 8.9 Hz, 1H), 7.37 (dd, J = 9.0, 2.0 Hz, 1H), 7.35−
7.26 (m, 4H), 7.26−7.18 (m, 6H), 7.17−7.11 (m, 2H), 6.47 (t, J = 6.8
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 148.3, 140.2, 138.3, 136.7,
133.4, 132.5, 131.6, 130.4, 129.8, 129.4, 128.7, 128.0, 127.8, 127.7,
127.04, 127.00, 126.9, 126.8, 126.6, 123.3, 122.3, 118.0, 110.9; HRMS:
[M + H]+ calculated for C27H18ClN2: 405.1153, found 405.1154.
4-Methoxy-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ka). pale yellow solid (16.8 mg, 21%); mp 239−240 °C; 1H NMR
(400 MHz, CDCl3) δ 8.63 (d, J = 8.1 Hz, 1H), 7.81 (d, J = 9.2 Hz,
1H), 7.64 (t, J = 7.9 Hz, 1H), 7.32−7.24 (m, 4H), 7.21−7.15 (m, 2H),
7.12−7.06 (m, 5H), 7.04 (dd, J = 8.8, 4.5 Hz, 1H), 6.94 (d, J = 7.7 Hz,
1H), 6.45 (t, J = 6.8 Hz, 1H), 3.38 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 157.9, 148.3, 143.0, 141.0, 137.3, 131.9, 130.8, 130.4, 128.4,
128.3, 127.6, 127.5, 127.1, 126.7, 126.2, 125.1, 123.1, 122.5, 118.0,
</para>
3475

DOI: 10.1021/acs.joc.5b00059
J. Org. Chem. 2015, 80, 3471−3479

The Journal of Organic Chemistry
<para sub=“exp”>
116.2, 110.7, 108.4, 100.2, 56.0; HRMS: [M + H]+ calculated for
C28H21N2O: 401.1648, found 401.1651.
2-Methoxy-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3k′a). pale white solid (30.4 mg, 38%); mp 279−280 °C; 1H NMR
(400 MHz, CDCl3) δ 8.29 (d, J = 2.6 Hz, 1H), 7.84 (d, J = 9.4 Hz,
1H), 7.51 (d, J = 9.2 Hz, 1H), 7.34−7.27 (m, 5H), 7.26−7.20 (m,
5H), 7.19−7.16 (m, 2H), 7.13 (dd, J = 9.2, 2.7 Hz, 1H), 6.47 (t, J = 6.9
Hz, 1H), 4.08 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 158.5, 148.0,
140.5, 138.9, 137.2, 133.8, 131.7, 130.8, 129.5, 128.6, 127.8, 127.64,
127.62, 127.3, 126.74, 126.72, 126.5, 124.1, 123.3, 118.3, 118.0, 110.7,
102.1, 56.0; HRMS: [M + H]+ calculated for C28H21N2O: 401.1648,
found 401.1648.
10-Methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3la). pale yellow solid (58.4 mg, 76%); mp >300 °C; 1H NMR (400
MHz, CDCl3) δ 8.95 (d, J = 8.1 Hz, 1H), 7.67 (t, J = 7.2 Hz, 1H),
7.62−7.56 (m, 2H), 7.47 (ddd, J = 8.3, 6.9, 1.1 Hz, 1H), 7.34−7.28
(m, 3H), 7.26−7.16 (m, 7H), 7.13 (d, J = 7.2 Hz, 1H), 6.32 (dd, J =
7.2, 1.4 Hz, 1H), 2.38 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 148.8,
141.2, 138.9, 138.6, 137.2, 133.1, 131.8, 131.5, 130.6, 128.6, 127.8,
127.68, 127.66, 126.7, 126.24, 126.16, 126.1, 125.7, 123.1, 122.7,
116.2, 113.5, 21.7. One carbon is not visible due to overlapping peaks;
HRMS: [M + H]+ calculated for C28H21N2: 385.1699, found 385.1698.
9-Methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ma). white solid (53.8 mg, 70%); mp 288−289 °C; 1H NMR (400
MHz, CDCl3) δ 8.96 (d, J = 8.1 Hz, 1H), 7.74 (d, J = 9.3 Hz, 1H),
7.71−7.66 (m, 1H), 7.60 (d, J = 8.3 Hz, 1H), 7.51−7.45 (m, 1H),
7.36−7.29 (m, 3H), 7.28−7.18 (m, 7H), 7.15 (dd, J = 9.3, 1.4 Hz,
1H), 6.96 (s, 1H), 2.03 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
147.4, 141.1, 138.9, 137.3, 133.3, 131.8, 131.5, 130.6, 130.5, 128.6,
127.8, 127.74, 127.68, 126.9, 126.7, 126.4, 126.3, 126.2, 124.4, 123.1,
122.7, 120.1, 117.3, 18.6; HRMS: [M + H]+ calculated for C28H21N2:
385.1699, found 385.1699.
9-Fluoro-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3na). yellow solid (62.1 mg, 80%); mp 295−297 °C; 1H NMR (400
MHz, CDCl3) δ 8.94 (d, J = 8.1 Hz, 1H), 7.81 (dd, J = 9.9, 5.3 Hz,
1H), 7.71 (ddd, J = 8.0, 6.9, 1.1 Hz, 1H), 7.61 (d, J = 8.3 Hz, 1H), 7.51
(ddd, J = 8.3, 6.9, 1.3 Hz, 1H), 7.39−7.32 (m, 3H), 7.28−7.18 (m,
8H), 7.13 (dd, J = 5.1, 2.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ
151.6 (d, J = 234.0 Hz), 145.8, 142.0, 138.6, 136.4 (d, J = 19.6 Hz),
134.3, 131.72, 131.69, 130.5, 128.8, 128.2, 127.9, 127.8, 126.9, 126.61,
126.58, 126.5, 123.6 (d, J = 2.0 Hz), 123.0, 119.5 (d, J = 26.0 Hz),
118.3 (d, J = 8.8 Hz), 113.6, 113.1; HRMS: [M + H]+ calculated for
C27H18FN2: 389.1449, found 389.1446.
9-Chloro-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3oa). yellow solid (58.9 mg, 73%); mp 295−296 °C; 1H NMR (400
MHz, CDCl3) δ 8.94 (d, J = 8.1 Hz, 1H), 7.77 (d, J = 9.6 Hz, 1H),
7.71 (t, J = 7.4 Hz, 1H), 7.62 (d, J = 8.3 Hz, 1H), 7.51 (t, J = 7.5 Hz,
1H), 7.40−7.33 (m, 3H), 7.29−7.17 (m, 9H); 13C NMR (100 MHz,
CDCl3) δ 146.3, 141.6, 138.5, 136.5, 134.5, 131.8, 131.7, 130.4, 128.9,
128.5, 128.2, 127.9, 127.8, 126.9, 126.7, 126.6, 126.3, 124.6, 123.1,
122.9, 118.7, 118.2. One carbon is not visible due to overlapping
peaks; HRMS: [M + H]+ calculated for C27H18ClN2: 405.1153, found
405.1150.
3-Chloro-10-methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-
a]pyridine (3pa). pale yellow solid (68.5 mg, 82%); mp >300 °C; 1H
NMR (400 MHz, CDCl3) δ 8.87 (d, J = 8.7 Hz, 1H), 7.62 (dd, J = 8.7,
2.0 Hz, 1H), 7.57 (d, J = 1.8 Hz, 2H), 7.36−7.29 (m, 3H), 7.28−7.20
(m, 5H), 7.18−7.14 (m, 2H), 7.12 (d, J = 7.2 Hz, 1H), 6.35 (dd, J =
7.2, 1.6 Hz, 1H), 2.40 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 149.1,
141.0, 139.1, 138.1, 136.9, 132.5, 132.3, 132.2, 131.8, 130.4, 128.7,
128.0, 127.93, 127.89, 127.0, 126.8, 126.7, 125.8, 124.8, 124.5, 122.9,
116.2, 113.8, 21.8; HRMS: [M + H]+ calculated for C28H20ClN2:
419.1310, found 419.1312.
2-Chloro-10-methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-
a]pyridine (3qa). pale yellow solid (66.9 mg, 80%); mp 279−280 °C;
1H NMR (400 MHz, CDCl3) δ 8.90 (d, J = 2.1 Hz, 1H), 7.53 (s, 1H),
7.51 (d, J = 9.0 Hz, 1H), 7.36 (dd, J = 9.0, 2.3 Hz, 1H), 7.33−7.29 (m,
3H), 7.26−7.19 (m, 5H), 7.16−7.13 (m, 2H), 7.11 (d, J = 7.2 Hz,
1H), 6.32 (dd, J = 7.2, 1.6 Hz, 1H), 2.37 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 148.9, 140.3, 139.0, 138.4, 136.8, 132.8, 132.3, 131.7,
</para>
Article
<para sub=“exp”>
130.5, 129.7, 129.3, 128.7, 127.9, 127.8, 127.0, 126.92, 126.89, 126.7,
125.7, 123.2, 122.3, 116.2, 113.8, 21.7; HRMS: [M + H]+ calculated
for C28H20ClN2: 419.1314, found 419.1312.
3-Methoxy-9-methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-
a]pyridine (3ra). pale yellow solid (65.4 mg, 79%); mp 233−234 °C;
1H NMR (400 MHz, CDCl3) δ 8.86 (d, J = 8.9 Hz, 1H), 7.69 (d, J =
9.2 Hz, 1H), 7.36−7.29 (m, 4H), 7.26−7.16 (m, 7H), 7.11 (dd, J =
9.3, 1.6 Hz, 1H), 6.96 (d, J = 2.5 Hz, 1H), 6.93 (s, 1H), 3.70 (s, 3H),
2.01 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 158.1, 147.4, 141.3,
138.9, 137.3, 132.9, 132.4, 131.7, 130.5, 130.3, 128.5, 127.8, 127.7,
127.3, 126.7, 124.6, 124.4, 121.7, 121.1, 119.8, 117.0, 116.9, 108.2,
55.3, 18.5; HRMS: [M + H]+ calculated for C29H23N2O: 415.1805,
found 415.1810.
3-Fluoro-9-methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]-
pyridine (3sa). pale yellow solid (60.3 mg, 75%); mp 287−289 °C; 1H
NMR (400 MHz, CDCl3) δ 8.93 (dd, J = 9.0, 5.9 Hz, 1H), 7.70 (d, J =
9.3 Hz, 1H), 7.42 (td, J = 8.6, 2.5 Hz, 1H), 7.37−7.30 (m, 3H), 7.28−
7.12 (m, 9H), 6.94 (s, 1H), 2.02 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 161.3 (d, J = 254.6 Hz), 147.5, 141.1, 138.4, 137.0, 132.9 (d,
J = 9.0 Hz), 132.5 (d, J = 4.5 Hz), 131.7, 130.7, 130.4, 128.6, 128.1,
127.89, 127.88, 127.0, 125.4 (d, J = 9.0 Hz), 124.4, 123.1, 122.3, 120.2,
117.1, 115.7 (d, J = 24.5 Hz), 111.8 (d, J = 22.4 Hz), 18.5; HRMS:
[M + H]+ calculated for C28H20FN2: 403.1605, found 403.1606.
3-Chloro-9-methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-
a]pyridine (3ta). pale yellow solid (66.9 mg, 80%); mp 263−264 °C;
1H NMR (400 MHz, CDCl3) δ 8.87 (d, J = 8.7 Hz, 1H), 7.71 (d, J =
9.3 Hz, 1H), 7.62 (dd, J = 8.7, 2.0 Hz, 1H), 7.57 (d, J = 1.9 Hz, 1H),
7.37−7.31 (m, 3H), 7.29−7.21 (m, 5H), 7.20−7.12 (m, 3H), 6.94 (s,
1H), 2.02 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 147.6, 141.0,
138.1, 136.9, 132.5, 132.4, 132.2, 131.7, 130.9, 130.4, 128.6, 128.1,
127.94, 127.89, 127.1, 126.9, 126.7, 124.7, 124.6, 124.4, 122.9, 120.3,
117.2, 18.6; HRMS: [M + H]+ calculated for C28H20ClN2: 419.1310,
found 419.1306.
9-Fluoro-3-methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]-
pyridine (3ua). pale yellow solid (53.9 mg, 67%); mp 291−292 °C;
1H NMR (400 MHz, CDCl3) δ 8.83 (d, J = 8.3 Hz, 1H), 7.77 (dd, J =
9.8, 5.3 Hz, 1H), 7.54 (dd, J = 8.3, 1.2 Hz, 1H), 7.37 (s, 1H), 7.36−
7.30 (m, 3H), 7.28−7.16 (m, 8H), 7.09 (dd, J = 5.1, 2.0 Hz, 1H), 2.44
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 151.6 (d, J = 233.8 Hz),
145.7, 142.1, 138.7, 136.6, 136.4, 133.9, 131.9, 131.7, 130.5, 128.8,
128.6, 128.1, 127.7, 127.2, 126.8, 126.6, 124.4, 123.2 (d, J = 2.2 Hz),
122.9, 119.2 (d, J = 26.0 Hz), 118.1 (d, J = 8.8 Hz), 113.3, 113.1,
22.2; HRMS: [M + H]+ calculated for C28H20FN2: 403.1605, found
403.1602.
9-Chloro-3-methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-
a]pyridine (3va). yellow solid (58.5 mg, 70%); mp 282−283 °C; 1H
NMR (400 MHz, CDCl3) δ 8.82 (d, J = 8.3 Hz, 1H), 7.73 (d, J = 9.6
Hz, 1H), 7.54 (dd, J = 8.3, 1.1 Hz, 1H), 7.39−7.32 (m, 4H), 7.29−
7.16 (m, 8H), 7.15 (d, J = 1.7 Hz, 1H), 2.44 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 146.2, 141.6, 138.6, 136.6, 136.4, 134.0, 131.9, 131.7,
130.4, 128.8, 128.6, 128.3, 128.1, 127.7, 127.1, 126.8, 126.6, 124.5,
124.3, 123.0, 122.5, 118.5, 118.1, 22.2; HRMS: [M + H]+ calculated
for C28H20ClN2: 419.1310, found 419.1313.
3-Methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine-
10-carbonitrile (3wa). yellow solid (53.2 mg, 65%); mp >300 °C; 1H
NMR (400 MHz, CDCl3) δ 8.84 (d, J = 8.3 Hz, 1H), 8.19 (s, 1H),
7.59 (d, J = 7.6 Hz, 1H), 7.40−7.33 (m, 4H), 7.30−7.21 (m, 6H),
7.20−7.16 (m, 2H), 6.58 (dd, J = 7.3, 1.6 Hz, 1H), 2.46 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ 145.5, 142.8, 138.2, 137.3, 136.4, 136.0,
132.3, 131.5, 130.5, 129.1, 128.9, 128.3, 127.8, 127.4, 127.2, 127.1,
126.4, 124.2, 124.1, 123.3, 123.1, 117.7, 110.4, 109.4, 22.3; HRMS:
[M + H]+ calculated for C29H20N3: 410.1652, found 410.1656.
3-Methoxy-11-methyl-5,6-diphenylnaphtho[1′,2′:4,5]imidazo-
[1,2-a]pyridine (3xa). yellow solid (32.3 mg, 39%); mp 216−218 °C;
1H NMR (400 MHz, CDCl3) δ 8.94 (d, J = 8.9 Hz, 1H), 7.34 (dd, J =
8.9, 2.5 Hz, 1H), 7.32−7.27 (m, 3H), 7.26−7.16 (m, 7H), 7.13 (d, J =
7.0 Hz, 1H), 7.07 (d, J = 6.7 Hz, 1H), 6.95 (d, J = 2.4 Hz, 1H), 6.38 (t,
J = 6.9 Hz, 1H), 3.71 (s, 3H), 2.78 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 158.1, 148.8, 141.1, 139.0, 137.3, 132.9, 132.7, 131.8, 130.6,
128.6, 127.8, 127.7, 127.5, 127.4, 126.7, 125.8, 125.0, 124.4, 122.3,
</para>
3476

DOI: 10.1021/acs.joc.5b00059
J. Org. Chem. 2015, 80, 3471−3479

The Journal of Organic Chemistry
<para sub=“exp”>
121.3, 116.9, 110.5, 108.1, 55.3, 17.9; HRMS: [M + H]+ calculated for
C29H23N2O: 415.1805, found 415.1808.
4,5-Diphenylthieno[3″,2″:5′,6′]benzo[1′,2′:4,5]imidazo[1,2-a]-
pyridine (3ya). white solid (70.0 mg, 93%); mp 266−267 °C; 1H
NMR (400 MHz, CDCl3) δ 7.77 (d, J = 9.1 Hz, 1H), 7.46 (d, J = 5.3
Hz, 1H), 7.36−7.31 (m, 4H), 7.31−7.18 (m, 8H), 7.16 (d, J = 5.3 Hz,
1H), 6.46 (t, J = 6.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 149.0,
139.4, 139.2, 138.4, 136.7, 131.18, 131.16, 131.0, 129.1, 128.7, 128.3,
128.0, 127.7, 127.2, 126.7, 125.54, 125.46, 124.5, 123.4, 117.9, 110.5;
HRMS: [M + H]+ calculated for C25H17N2S: 377.1107,
found
377.1108.
5,6-Di-p-tolylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine (3ab).
white solid (56.5 mg, 71%); mp 286−287 °C; 1H NMR (400 MHz,
CDCl3) δ 8.96 (d, J = 8.1 Hz, 1H), 7.83 (d, J = 8.9 Hz, 1H), 7.68 (ddd,
J = 8.0, 6.8, 0.9 Hz, 1H), 7.61 (d, J = 8.4 Hz, 1H), 7.47 (ddd, J = 8.3,
6.9, 1.2 Hz, 1H), 7.32−7.26 (m, 2H), 7.12 (d, J = 8.6 Hz, 4H), 7.09−
7.03 (m, 4H), 6.49 (td, J = 6.9, 1.1 Hz, 1H), 2.37 (s, 3H), 2.32 (s, 3H);
13C NMR (100 MHz, CDCl3) δ 148.2, 141.0, 137.4, 136.1, 135.8,
134.1, 133.9, 131.9, 131.6, 130.4, 129.4, 128.4, 127.8, 127.2, 126.9,
126.8, 126.3, 126.2, 123.1, 118.0, 110.6, 21.5, 21.4. DEPT 135 analysis
revealed that a quaternary carbon signal overlaps with the δ 126.8
signal and a tertiary carbon signal overlaps with the δ 126.2 signal.
HRMS: [M + H]+ calculated for C29H23N2: 399.1856, found 399.1855.
5,6-Bis(4-methoxyphenyl)naphtho[1′,2′:4,5]imidazo[1,2-a]-
pyridine (3ac). white solid (60.2 mg, 70%); mp 285−287 °C; 1H
NMR (400 MHz, CDCl3) δ 8.96 (d, J = 7.9 Hz, 1H), 7.84 (d, J = 9.1
Hz, 1H), 7.69 (t, J = 7.3 Hz, 1H), 7.63 (d, J = 8.4 Hz, 1H), 7.49 (t, J =
7.6 Hz, 1H), 7.38 (d, J = 6.8 Hz, 1H), 7.33−7.28 (m, 1H), 7.14 (d, J =
8.2 Hz, 2H), 7.09 (d, J = 8.2 Hz, 2H), 6.87 (d, J = 8.1 Hz, 2H), 6.81
(d, J = 8.2 Hz, 2H), 6.52 (t, J = 6.8 Hz, 1H), 3.84 (s, 3H), 3.80 (s,
3H); 13C NMR (100 MHz, CDCl3) δ 159.0, 158.3, 133.9, 132.8,
132.1, 131.6, 131.2, 129.4, 127.8, 127.3, 126.83, 126.78, 126.31,
126.25, 123.1, 118.0, 114.2, 113.3, 110.7, 55.4, 55.3. Four carbons are
not visible due to signal overlapping. HRMS: [M + H]+ calculated for
C29H23N2O2: 431.1754, found 431.1759.
5,6-Bis(4-chlorophenyl)naphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ad). white solid (68.5 mg, 78%); mp 281−282 °C; 1H NMR (400
MHz, CDCl3) δ 8.96 (d, J = 8.0 Hz, 1H), 7.84 (d, J = 9.2 Hz, 1H),
7.71 (t, J = 7.0 Hz, 1H), 7.57−7.47 (m, 2H), 7.39−7.29 (m, 4H), 7.25
(d, J = 7.9 Hz, 2H), 7.17 (d, J = 8.0 Hz, 2H), 7.09 (d, J = 8.0 Hz, 2H),
6.56 (t, J = 6.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 148.3, 141.4,
137.0, 135.4, 134.2, 133.1, 133.0, 132.5, 131.8, 131.3, 129.2, 128.2,
127.6, 127.4, 126.7, 126.6, 126.4, 126.3, 125.6, 123.3, 122.4, 118.2,
111.1; HRMS: [M + H]+ calculated for C27H17Cl2N2: 439.0763, found
439.0767.
5,6-Bis(4-bromophenyl)naphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ae). pale yellow solid (70.7 mg, 67%); mp 292−294 °C; 1H NMR
(400 MHz, CDCl3) δ 8.96 (d, J = 8.1 Hz, 1H), 7.84 (d, J = 9.3 Hz,
1H), 7.70 (ddd, J = 8.0, 6.3, 1.7 Hz, 1H), 7.56−7.46 (m, 4H), 7.41 (d,
J = 8.3 Hz, 2H), 7.35−7.30 (m, 2H), 7.11 (d, J = 8.3 Hz, 2H), 7.03 (d,
J = 8.3 Hz, 2H), 6.57 (t, J = 6.5 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ 148.3, 141.4, 137.5, 135.8, 133.3, 132.4, 132.1, 131.24,
131.17, 127.6, 127.4, 126.7, 126.6, 126.4, 126.3, 125.5, 123.3, 122.4,
122.3, 121.3, 118.2, 111.2. One carbon is not visible due to over-
lapping peaks; HRMS: [M + H]+ calculated for C27H17Br2N2: 526.9753,
found 526.9756.
5,6-Bis(4-(triﬂuoromethyl)phenyl)naphtho[1′,2′:4,5]imidazo[1,2-
a]pyridine (3af). white solid (90.0 mg, 89%); mp >300 °C; 1H NMR
(400 MHz, CDCl3) δ 8.99 (d, J = 8.2 Hz, 1H), 7.86 (d, J = 9.2 Hz,
1H), 7.74 (ddd, J = 8.1, 6.7, 1.3 Hz, 1H), 7.63 (d, J = 8.0 Hz, 2H),
7.56−7.46 (m, 4H), 7.40 (d, J = 8.0 Hz, 2H), 7.35 (ddd, J = 9.1, 6.7,
1.0 Hz, 1H), 7.30 (d, J = 7.9 Hz, 2H), 7.24 (d, J = 7.1 Hz, 1H), 6.57
(td, J = 7.0, 1.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 148.5, 142.4,
141.7, 140.6, 132.2, 132.1, 131.0, 130.6 (q, J = 32.5 Hz), 129.5 (q, J =
32.4 Hz), 127.8, 127.3, 127.0, 126.9, 126.6, 126.1, 125.9 (q, J = 3.7
Hz), 125.3, 124.9 (q, J = 270.4 Hz), 124.3 (q, J = 3.7 Hz), 124.0 (q,
J = 270.7 Hz), 123.4, 122.1, 118.4, 111.4. One carbon is not visible
due to overlapping peaks; HRMS: [M + H]+ calculated for C29H17F6N2:
507.1290, found 507.1292.
</para>
Article
<para sub=“exp”>
5,6-Di-m-tolylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine (3ag).
pale yellow solid (37.5 mg, 47%); mp 245−247 °C; 1H NMR (400
MHz, CDCl3) δ 8.97 (d, J = 8.1 Hz, 1H), 7.84 (d, J = 9.2 Hz, 1H),
7.69 (t, J = 7.5 Hz, 1H), 7.63 (d, J = 8.3 Hz, 1H), 7.49 (ddd, J = 8.1,
6.8, 1.0 Hz, 1H), 7.33−7.27 (m, 2H), 7.24−7.18 (m, 1H), 7.17−7.09
(m, 2H), 7.09−6.97 (m, 5H), 6.50 (t, J = 6.8 Hz, 1H), 2.29 (d, J = 4.2
Hz, 3H), 2.27 (d, J = 6.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ
148.2, 141.0, 138.7, 138.3, 138.2, 137.1, 137.03, 136.98, 133.84,
133.81, 132.6, 132.5, 131.7, 131.3, 131.2, 128.9, 128.8, 128.54, 128.52,
128.5, 128.4, 127.9, 127.59, 127.56, 127.5, 127.4, 127.3, 126.9, 126.8,
126.2, 123.1, 118.0, 110.7, 21.57, 21.56, 21.52, 21.51; HRMS: [M +
H]+ calculated for C29H23N2: 399.1856, found 399.1860.
5,6-Bis(2-ﬂuorophenyl)naphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ah). pale yellow solid (34.9 mg, 43%); mp 276−277 °C; 1H NMR
(400 MHz, CDCl3) δ 9.00 (d, J = 8.1 Hz, 1H), 7.87 (d, J = 9.2 Hz,
1H), 7.73 (ddd, J = 8.1, 5.2, 2.8 Hz, 1H), 7.58−7.50 (m, 2H), 7.42 (d,
J = 6.6 Hz, 1H), 7.39−7.29 (m, 3H), 7.29−7.21 (m, 2H), 7.17−6.98
(m, 4H), 6.57 (td, J = 7.0, 1.0 Hz, 1H); 13C NMR (100 MHz, CDCl3)
δ 160.6 (d, J = 243.2 Hz), 159.9 (d, J = 244.6 Hz), 148.3, 141.8, 132.8
(d, J = 2.8 Hz), 131.7 (d, J = 1.2 Hz), 131.3, 130.8 (d, J = 7.7 Hz),
129.7 (d, J = 7.9 Hz), 128.3, 127.6, 127.0, 126.8, 126.69, 126.65, 126.4
(d, J = 17.2 Hz), 125.9, 124.73 (d, J = 3.6 Hz), 124.72 (d, J = 16.9 Hz),
123.9 (d, J = 3.6 Hz), 123.4, 122.8, 121.0, 118.2, 115.7 (d, J = 21.5
Hz), 115.1 (d, J = 22.1 Hz), 111.4; HRMS: [M + H]+ calculated for
C27H17F2N2: 407.1354, found 407.1356.
5,6-Di(thiophen-2-yl)naphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ai). pale yellow solid (25.2 mg, 33%); mp >300 °C; 1H NMR (400
MHz, CDCl3) δ 8.95 (d, J = 8.2 Hz, 1H), 7.87−7.83 (m, 2H), 7.73 (t,
J = 7.5 Hz, 1H), 7.56 (t, J = 7.7 Hz, 1H), 7.44 (d, J = 5.1 Hz, 1H),
7.41−7.32 (m, 3H), 7.13−6.94 (m, 4H), 6.62 (t, J = 6.9 Hz, 1H); 13C
NMR (100 MHz, CDCl3) δ 148.6, 141.8, 138.9, 137.0, 132.4, 130.1,
129.3, 128.2, 127.9, 127.8, 127.6, 127.5, 127.1, 126.8, 126.72, 126.67,
126.53, 126.50, 123.3, 123.2, 121.2, 118.1, 111.3; HRMS: [M + H]+
calculated for C23H15N2S2: 383.0671, found 383.0676.
Diethyl naphtho[1′,2′:4,5]imidazo[1,2-a]pyridine-5,6-dicarboxy-
late (3aj). pale yellow solid (61.5 mg, 85%); mp 128−129 °C; 1H
NMR (400 MHz, CDCl3) δ 8.92 (d, J = 8.1 Hz, 1H), 8.75 (d, J = 7.1
Hz, 1H), 8.32 (d, J = 8.5 Hz, 1H), 7.86 (d, J = 9.1 Hz, 1H), 7.77 (t, J =
7.5 Hz, 1H), 7.69 (t, J = 7.7 Hz, 1H), 7.45 (dd, J = 8.8, 7.0 Hz, 1H),
6.90 (t, J = 6.9 Hz, 1H), 4.62−4.48 (m, 4H), 1.47 (t, J = 7.2 Hz, 6H);
13C NMR (100 MHz, CDCl3) δ 168.0, 167.0, 149.6, 143.8, 129.0,
128.2, 128.0, 127.7, 127.6, 127.5, 126.6, 125.3, 123.6, 119.5, 119.3,
118.2, 111.9, 62.7, 62.1, 14.4, 14.2; HRMS: [M + H]+ calculated for
C21H19N2O4: 363.1339, found 363.1340.
5-Methyl-6-phenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine
(3ak). pale yellow solid (20.3 mg, 33%); mp 179−180 °C; 1H NMR
(400 MHz, CDCl3) δ 8.95 (d, J = 8.0 Hz, 1H), 8.20 (d, J = 8.2 Hz,
1H), 7.80 (d, J = 9.1 Hz, 1H), 7.74 (t, J = 7.4 Hz, 1H), 7.68 (t, J = 7.5
Hz, 1H), 7.64−7.56 (m, 3H), 7.44−7.38 (m, 2H), 7.25 (t, J = 7.9 Hz,
1H), 7.17 (d, J = 7.1 Hz, 1H), 6.46 (t, J = 6.9 Hz, 1H), 2.53 (s, 3H);
13C NMR (100 MHz, CDCl3) δ 147.7, 140.2, 138.2, 131.5, 130.1,
129.5, 128.5, 126.9, 126.7, 126.53, 126.49, 126.4, 126.3, 125.3, 123.7,
123.1, 118.0, 110.6, 16.0. One carbon is not visible due to overlapping
peaks; HRMS: [M + H]+ calculated for C22H17N2: 309.1386, found
309.1390.
5-(4-Methoxyphenyl)-6-(4-(triﬂuoromethyl)phenyl)naphtho-
[1′,2′:4,5]imidazo[1,2-a]pyridine (3al) and 6-(4-methoxyphenyl)-5-
(4-(triﬂuoromethyl)phenyl)naphtho[1′,2′:4,5]imidazo[1,2-a]-
pyridine (3al′). pale yellow solid (84.2 mg, 90% in total). Selected
signals: Major: 1H NMR (400 MHz, CDCl3) δ 8.96 (d, J = 8.1 Hz,
1H), 7.84 (d, J = 9.2 Hz, 1H), 7.73−7.66 (m, 1H), 7.61 (t, J = 9.2 Hz,
2H), 7.53−7.46 (m, 2H), 7.36 (d, J = 7.7 Hz, 2H), 7.30 (dd, J = 11.1,
5.7 Hz, 2H), 7.03 (d, J = 8.4 Hz, 2H), 6.77 (d, J = 8.4 Hz, 2H), 6.52 (t,
J = 6.8 Hz, 1H), 3.78 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 158.6,
148.2, 132.6, 131.1, 125.6 (q, J = 3.7 Hz), 118.2, 113.4, 111.1, 55.3.
Minor: 1H NMR (400 MHz, CDCl3) δ 8.96 (d, J = 8.1 Hz, 1H), 7.84
(d, J = 9.2 Hz, 1H), 7.73−7.66 (m, 1H), 7.61 (t, J = 9.2 Hz, 2H),
7.53−7.46 (m, 2H), 7.36 (d, J = 7.7 Hz, 1H), 7.30 (dd, J = 11.1, 5.7
Hz, 1H), 7.22 (d, J = 7.0 Hz, 2H), 7.10 (d, J = 8.4 Hz, 2H), 6.86 (d,
J = 8.4 Hz, 2H), 6.52 (t, J = 6.8 Hz, 1H), 3.82 (s, 3H). 13C NMR
</para>
3477

DOI: 10.1021/acs.joc.5b00059
J. Org. Chem. 2015, 80, 3471−3479

The Journal of Organic Chemistry
<para sub=“exp”>
(100 MHz, CDCl3) δ 159.3, 148.3, 124.7 (d, J = 3.8 Hz), 118.0, 114.3,
111.0, 55.4; HRMS: [M + H]+ calculated for C29H20F3N2O: 469.1522,
found 469.1522.
Methyl 6-phenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine-5-car-
boxylate (3am) and methyl 5-phenylnaphtho[1′,2′:4,5]imidazo-
[1,2-a]pyridine-6-carboxylate (3am′). pale yellow solid (57.0 mg,
81% in total). Selected signals: Major: 1H NMR (400 MHz, CDCl3) δ
8.94 (d, J = 8.1 Hz, 1H), 8.47 (d, J = 7.0 Hz, 1H), 7.88 (d, J = 9.1 Hz,
1H), 6.88 (t, J = 6.8 Hz, 1H), 3.60 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 168.7, 148.4, 141.7, 138.3, 133.7, 130.8, 129.7, 129.1, 128.2,
127.9, 127.6, 126.7, 126.4, 123.3, 118.2, 111.7, 52.5. Minor: 1H NMR
(400 MHz, CDCl3) δ 8.94 (d, J = 8.1 Hz, 1H), 8.03 (d, J = 8.3 Hz,
1H), 7.83 (d, J = 9.1 Hz, 1H), 7.37−7.30 (m, 1H), 6.54 (t, J = 6.9 Hz,
1H), 3.62 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 169.5, 149.0,
142.5, 135.9, 130.7, 129.0, 128.4, 128.3, 126.9, 126.8, 126.2, 126.0,
125.8, 123.5, 121.8, 119.9, 111.3, 52.1; HRMS: [M + H]+ calculated
for C23H17N2O2: 353.1285, found 353.1289.
Ethyl 6-phenylnaphtho[1′,2′:4,5]imidazo[1,2-a]pyridine-5-car-
boxylate (3an) and ethyl 5-phenylnaphtho[1′,2′:4,5]imidazo[1,2-
a]pyridine-6-carboxylate (3an′). pale yellow solid (54.9 mg, 75% in
total). Selected signals: Major: 1H NMR (400 MHz, CDCl3) δ 8.95 (d,
J = 7.3 Hz, 1H), 8.54 (d, J = 7.0 Hz, 1H), 7.89 (d, J = 9.1 Hz, 1H),
6.88 (t, J = 6.8 Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 0.93 (t, J = 7.1 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 168.3, 138.4, 133.5, 131.0,
129.9, 129.0, 128.2, 128.0, 127.9, 127.6, 126.7, 123.3, 118.2, 111.6,
62.0, 13.6. Minor: 1H NMR (400 MHz, CDCl3) δ 8.95 (d, J = 7.3 Hz,
1H), 8.08 (d, J = 8.3 Hz, 1H), 7.83 (d, J = 9.0 Hz, 1H), 7.37−7.29 (m,
1H), 6.53 (t, J = 6.8 Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 0.98 (t, J = 7.1
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 169.0, 135.9, 130.8, 128.5,
127.4, 127.3, 126.6, 126.23, 126.19, 123.5, 118.9, 118.2, 111.2, 61.3,
13.9; HRMS: [M + H]+ calculated for C24H19N2O2: 367.1441, found
367.1438.

General procedures for synthesis of 4. 2-Phenylimidazo[1,2-
a]pyridines (0.20 mmol), alkynes (0.20 mmol), [RhCp*Cl2]2 (4 mol %),
AgBF4 (1.0 equiv), Cu(OAc)2 (1.0 equiv) and DCE (3 mL) were charged
into the sealed tube. The reaction mixture was stirred at 100 °C for 24 h.
After cooled to room temperature, the solvent was removed under reduced
pressure and the residue was puriﬁed by silica gel chromatography using
CH2Cl2/MeOH to aﬀord the desired product 4.
5,6-Diphenylpyrido[2′,1′:2,3]imidazo[5,1-a]isoquinolin-7-ium
tetraﬂuoroborate (4a). brown solid (80.6 mg, 88%); 1H NMR (400
MHz, DMSO-d6) δ 9.63 (s, 1H), 9.21 (d, J = 5.4 Hz, 1H), 8.66 (d, J =
7.9 Hz, 1H), 7.87 (t, J = 7.5 Hz, 1H), 7.80−7.67 (m, 3H), 7.63−7.47
(m, 5H), 7.42−7.26 (m, 5H), 7.21 (d, J = 8.1 Hz, 1H), 6.04 (d, J = 8.3
Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 134.5, 134.1, 132.1,
131.7, 131.3, 131.22, 131.19, 130.8, 130.6, 130.4, 129.9, 129.61,
129.56, 129.2, 128.2, 127.9, 127.6, 126.6, 124.5, 120.5, 119.0, 113.1.
One carbon is not visible due to overlapping peaks; 19F NMR (376
MHz, DMSO-d6) δ −148.35, −148.41. The two signals in the 19F
NMR spectrum are due to presence of 10B and 11B isotopes. However,
no ﬁne coupling was detected. HRMS: [M − BF4] calculated for
C27H19N2: 371.1543, found 371.1542.
3-Methyl-5,6-diphenylpyrido[2′,1′:2,3]imidazo[5,1-a]isoquinolin-
7-ium tetraﬂuoroborate (4b). brown solid (79.3 mg, 84%); 1H NMR
(400 MHz, DMSO-d6) δ 9.56 (s, 1H), 9.19 (d, J = 4.2 Hz, 1H), 8.54
(d, J = 8.1 Hz, 1H), 7.69 (s, 3H), 7.62−7.46 (m, 5H), 7.41−7.26 (m,
5H), 6.99 (s, 1H), 6.10−5.95 (m, 1H), 2.36 (s, 3H); 13C NMR
(100 MHz, DMSO-d6) δ 141.3, 134.3, 134.1, 132.1, 131.8, 131.3,
131.0, 130.81, 130.75, 130.6, 130.4, 130.0, 129.5, 129.2, 128.2, 127.9,
127.6, 126.3, 124.4, 118.9, 118.1, 113.0, 107.2, 21.5; 19F NMR (376
MHz, DMSO-d6) δ −148.33, −148.38. The two signals in the 19F
NMR spectrum are due to presence of 10B and 11B isotopes. However,
no ﬁne coupling was detected. HRMS: [M − BF4] calculated for
C28H21N2: 385.1699, found 385.1703.
10-Chloro-5,6-diphenylpyrido[2′,1′:2,3]imidazo[5,1-a]-
isoquinolin-7-ium tetraﬂuoroborate (4c). brown solid (77.7 mg,
79%); 1H NMR (400 MHz, DMSO-d6) δ 9.55 (s, 2H), 8.74 (d, J = 7.5
Hz, 1H), 7.96−7.81 (m, 2H), 7.77 (t, J = 7.0 Hz, 1H), 7.63−7.47 (m,
5H), 7.41−7.20 (m, 6H), 6.01 (d, J = 9.9 Hz, 1H); 13C NMR
(100 MHz, DMSO-d6) δ 133.9, 133.2, 132.0, 131.9, 131.5, 131.42,
</para>
Article
<para sub=“exp”>
131.35, 130.8, 130.6, 130.0, 129.7, 129.3, 128.3, 127.9, 127.5, 126.7,
125.5, 124.7, 120.3, 113.8, 108.0. Two carbons are not visible due to over-
lapping peaks; 19F NMR (376 MHz, DMSO) δ −148.41, −148.46. The
two signals in the 19F NMR spectrum are due to presence of 10B and 11B
isotopes. However, no ﬁne coupling was detected. HRMS: [M − BF4]
calculated for C27H18ClN2: 405.1153, found 405.1157.
3-Chloro-9-methyl-5,6-diphenylpyrido[2′,1′:2,3]imidazo[5,1-a]-
isoquinolin-7-ium tetraﬂuoroborate (4d). brown solid (80.9 mg,
80%); 1H NMR (400 MHz, DMSO-d6) δ 9.54 (s, 1H), 9.12 (d, J = 6.7
Hz, 1H), 8.68 (d, J = 8.3 Hz, 1H), 7.92 (d, J = 8.1 Hz, 1H), 7.66−7.49
(m, 6H), 7.44−7.29 (m, 5H), 7.06 (s, 1H), 5.62 (s, 1H), 2.22 (s, 3H);
13C NMR (100 MHz, DMSO-d6) δ 143.4, 135.5, 134.8, 133.5, 133.4,
131.6, 131.5, 130.73, 130.65, 130.4, 130.3, 129.5, 129.2, 128.9, 128.5,
128.2, 126.6, 126.0, 125.5, 121.0, 119.5, 112.0, 107.8, 21.8; 19F NMR
(376 MHz, DMSO-d6) δ −148.33, −148.39. The two signals in the 19F
NMR spectrum are due to presence of 10B and 11B isotopes. However,
no ﬁne coupling was detected. HRMS: [M − BF4] calculated for
C28H20ClN2: 419.1310, found 419.1311.
5,6-Bis(4-methoxyphenyl)pyrido[2′,1′:2,3]imidazo[5,1-a]-
isoquinolin-7-ium tetraﬂuoroborate (4e). brown solid (78.7 mg,
76%); 1H NMR (400 MHz, DMSO-d6) δ 9.60 (s, 1H), 9.20 (d, J = 4.2
Hz, 1H), 8.62 (d, J = 6.8 Hz, 1H), 7.90−7.65 (m, 4H), 7.50 (d, J = 7.2
Hz, 2H), 7.31−7.16 (m, 3H), 7.10 (d, J = 7.2 Hz, 2H), 6.95 (d, J = 7.0
Hz, 2H), 6.18 (d, J = 8.6 Hz, 1H), 3.83 (s, 3H), 3.76 (s, 3H); 13C
NMR (100 MHz, DMSO-d6) δ 160.2, 158.5, 134.5, 132.3, 132.2,
131.8, 131.3, 131.0, 130.4, 129.5, 129.3, 127.70, 126.65, 126.3, 124.3,
123.9, 120.4, 118.9, 114.6, 113.7, 113.3, 107.6, 55.2, 55.0. One carbon
is not visible due to overlapping peaks; 19F NMR (376 MHz, DMSO-
d6) δ −148.34, −148.39. The two signals in the 19F NMR spectrum are
due to presence of 10B and 11B isotopes. However, no ﬁne coupling was
detected. HRMS: [M − BF4] calculated for C29H23N2O2: 431.1754,
found 431.1757.
5,6-Bis(4-chlorophenyl)pyrido[2′,1′:2,3]imidazo[5,1-a]-
isoquinolin-7-ium tetraﬂuoroborate (4f). brown solid (74.8 mg,
71%); 1H NMR (400 MHz, DMSO-d6) δ 9.64 (s, 1H), 9.23 (d, J = 6.0
Hz, 1H), 8.67 (d, J = 7.5 Hz, 1H), 7.96−7.80 (m, 2H), 7.75 (d, J = 6.4
Hz, 2H), 7.62 (s, 4H), 7.46 (d, J = 7.7 Hz, 2H), 7.31 (d, J = 7.5 Hz,
2H), 7.21 (d, J = 7.8 Hz, 1H), 6.30 (d, J = 9.1 Hz, 1H); 13C NMR
(100 MHz, DMSO-d6) δ 135.3, 134.5, 132.9, 132.8, 132.7, 132.5,
131.9, 131.3, 131.2, 131.1, 130.4, 129.8, 129.7, 129.6, 129.5, 128.5,
127.0, 126.6, 124.5, 120.6, 119.1, 113.1, 107.8. The two signals in the
19F NMR spectrum are due to presence of 10B and 11B isotopes. How-
ever, no ﬁne coupling was detected. 19F NMR (376 MHz, DMSO-d6)
δ −148.34, −148.39; HRMS: [M − BF4] calculated for C27H17Cl2N2:
439.0763, found 439.0762.

Procedure for Synthesis of Complex 5. 2-Phenylimidazo[1,2-
a]pyridine (0.15 mmol, 29.1 mg), [RhCp*Cl2]2 (0.07 mmol, 43.3 mg),
NaOAc (6 equiv, 34.3 mg), and CH2Cl2 (4 mL) were charged into the
sealed tube. The reaction mixture was stirred at room temperature for
12 h. After ﬁltration, the solvent was removed under reduced pressure
and the residue was washed with Et2O ﬁve times to aﬀord complex 5
(48.3 mg, 74%). 1H NMR (400 MHz, CDCl3) δ 8.06 (s, 1H), 7.82 (s,
1H), 7.56 (d, J = 32.3 Hz, 2H), 7.36−7.12 (m, 3H), 6.98 (s, 1H), 6.67
(s, 1H), 1.64 (s, 15H); 13C NMR (100 MHz, CDCl3) δ 174.4 (d, JRh−C =
31.2 Hz), 152.3, 143.8, 139.0, 137.1, 128.4, 127.9, 125.9, 122.7, 121.9,
114.2, 112.8, 105.7, 95.1 (d, JRh−C = 6.2 Hz), 9.8. HRMS: [M − Cl]+
calculated for C23H24N2Rh: 431.0995, found 431.1006.
</para>
■ ASSOCIATED CONTENT
*S Supporting Information
1H and 13C NMR spectra of all new products and crystallo-
graphic data of 3ka′ (including CIF). This material is available
free of charge via the Internet at http://pubs.acs.org.

■ AUTHOR INFORMATION

Corresponding Author
*E-mail: xwli@dicp.ac.cn.

3478

DOI: 10.1021/acs.joc.5b00059
J. Org. Chem. 2015, 80, 3471−3479

The Journal of Organic Chemistry

Notes
The authors declare no competing ﬁnancial interest.

■ ACKNOWLEDGMENTS

We are grateful to the National Natural Science Foundation of
China (grant nos. 21272231, 21402190, and 21472186) and
Dalian Institute of Chemical Physics, Chinese Academy of
Sciences,
for ﬁnancial support. We thank Prof. Mei Wang,
Mr. Zhongkai Lu, and Mr. Shuai Zhang (Dalian University of
Technology) for their help on absorption and emission spectra.

■ REFERENCES

Itami, K. Angew. Chem.,

(1) (a) Allard, S.; Forster, M.; Souharce, B.; Thiem, H.; Scherf, U.
Angew. Chem., Int. Ed. 2008, 47, 4070. (b) Facchetti, A. Chem. Mater.
2011, 23, 733. (c) Wang, C.; Dong, H.; Hu, W.; Liu, Y.; Zhu, D. Chem.
Rev. 2012, 112, 2208.
(2) (a) Ritleng, V.; Sirlin, C.; Pfeffer, M. Chem. Rev. 2002, 102, 1731.
(b) Ackermann, L.; Vicente, R.; Kapdi, A. R. Angew. Chem., Int. Ed.
2009, 48, 9792. (c) Colby, D. A.; Bergman, R. G.; Ellman, J. A. Chem.
Rev. 2010, 110, 624. (d) Lyons, T. W.; Sanford, M. S. Chem. Rev. 2010,
110, 1147. (e) Sun, C.-L.; Li, B.-J.; Shi, Z.-J. Chem. Rev. 2010, 111,
1293. (f) Ackermann, L. Chem. Rev. 2011, 111, 1315. (g) Cho, S. H.;
Kim, J. Y.; Kwak, J.; Chang, S. Chem. Soc. Rev. 2011, 40, 5068.
(h) Wencel-Delord, J.; Droge, T.; Liu, F.; Glorius, F. Chem. Soc. Rev.
2011, 40, 4740. (i) Wendlandt, A. E.; Suess, A. M.; Stahl, S. S. Angew.
Chem., Int. Ed. 2011, 50, 11062. (j) Yeung, C. S.; Dong, V. M. Chem.
Rev. 2011, 111, 1215. (k) Arockiam, P. B.; Bruneau, C.; Dixneuf, P. H.
Chem. Rev. 2012, 112, 5879. (l) Engle, K. M.; Mei, T.-S.; Wasa, M.; Yu,
J.-Q. Acc. Chem. Res. 2012, 45, 788. (m) Kuhl, N.; Hopkinson, M. N.;
Wencel-Delord, J.; Glorius, F. Angew. Chem., Int. Ed. 2012, 51, 10236.
(n) White, M. C. Science 2012, 335, 807. (o) Yamaguchi,
J.;
Yamaguchi, A. D.; Itami, K. Angew. Chem., Int. Ed. 2012, 51, 8960.
(p) Shang, X.; Liu, Z.-Q. Chem. Soc. Rev. 2013, 42, 3253. (q) Yan, G.;
Wu, X.; Yang, M. Org. Biomol. Chem. 2013, 11, 5558. (r) Ackermann,
L. Acc. Chem. Res. 2014, 47, 281. (s) Zhang, M.; Zhang, Y.; Jie, X.;
Zhao, H.; Li, G.; Su, W. Org. Chem. Front. 2014, 1, 843. (t) Segawa, Y.;
Int. Ed. 2015, 54, 66.
Maekawa, T.;
(u) Gutekunst, W. R.; Baran, P. S. Chem. Soc. Rev. 2011, 40, 1976.
(v) McMurray, L.; O’Hara, F.; Gaunt, M. J. Chem. Soc. Rev. 2011, 40,
1885. (w) Chen, D. Y. K.; Youn, S. W. Chem.Eur. J. 2012, 18, 9452.
(3) (a) Colby, D. A.; Tsai, A. S.; Bergman, R. G.; Ellman, J. A. Acc.
Chem. Res. 2011, 45, 814. (b) Song, G.; Wang, F.; Li, X. Chem. Soc.
Rev. 2012, 41, 3651. (c) Kuhl, N.; Schröder, N.; Glorius, F. Adv. Synth.
Catal. 2014, 356, 1443. (d) Patureau, F. W.; Besset, T.; Fröhlich, R.;
Glorius, F. Aldrichim. Acta 2012, 45, 31.
(4) (a) Satoh, T.; Miura, M. Chem.Eur. J. 2010, 16, 11212.
(b) Chen, J.; Song, G.; Pan, C.-L.; Li, X. Org. Lett. 2010, 12, 5426.
(c) Morimoto, K.; Hirano, K.; Satoh, T.; Miura, M. J. Org. Chem. 2011,
76, 9548. (d) Patureau, F. W.; Besset, T.; Kuhl, N.; Glorius, F. J. Am.
Chem. Soc. 2011, 133, 2154. (e) Pham, M. V.; Ye, B.; Cramer, N.
Angew. Chem., Int. Ed. 2012, 51, 10610. (f) Wang, D.; Wang, F.; Song,
G.; Li, X. Angew. Chem., Int. Ed. 2012, 51, 12348. (g) Chen, Y.; Wang,
F.; Zhen, W.; Li, X. Adv. Synth. Catal. 2013, 355, 353. (h) Park, S.; Seo,
B.; Shin, S.; Son, J. Y.; Lee, P. H. Chem. Commun. 2013, 49, 8671.
(i) Seo, J.; Park, Y.; Jeon, I.; Ryu, T.; Park, S.; Lee, P. H. Org. Lett.
2013, 15, 3358. (j) Unoh, Y.; Hashimoto, Y.; Takeda, D.; Hirano, K.;
Satoh, T.; Miura, M. Org. Lett. 2013, 15, 3258. (k) Wang, C.; Sun, H.;
Fang, Y.; Huang, Y. Angew. Chem., Int. Ed. 2013, 52, 5795. (l) Itoh, M.;
Shimizu, M.; Hirano, K.; Satoh, T.; Miura, M. J. Org. Chem. 2013, 78,
11427. (m) Burns, D. J.; Lam, H. W. Angew. Chem., Int. Ed. 2014, 53,
9931. (n) Seoane, A.; Casanova, N.; Quinones, N.; Mascarenas, J. L.;
Gulias, M. J. Am. Chem. Soc. 2014, 136, 7607. (o) Seoane, A.;
Casanova, N.; Quiñones, N.; Mascareñas, J. L.; Gulías, M. J. Am. Chem.
Soc. 2014, 136, 834. (p) Zhang, X.; Li, Y.; Shi, H.; Zhang, L.; Zhang,
S.; Xu, X.; Liu, Q. Chem. Commun. 2014, 50, 7306. (q) Qi, Z.; Wang,
M.; Li, X. Chem. Commun. 2014, 50, 9776. (r) Kujawa, S.; Best, D.;
Burns, D. J.; Lam, H. W. Chem.Eur. J. 2014, 20, 8599. (s) Chen, Y.;
Wang, D.; Duan, P.; Ben, R.; Dai, L.; Shao, X.; Hong, M.; Zhao, J.;

Article

Huang, Y. Nat. Commun. 2014, 5, 4610. (t) Sun, H.; Wang, C.; Yang,
Y.-F.; Chen, P.; Wu, Y.-D.; Zhang, X.; Huang, Y. J. Org. Chem. 2014,
79, 11863.
(5) Umeda, N.; Tsurugi, H.; Satoh, T.; Miura, M. Angew. Chem., Int.
Ed. 2008, 47, 4019.
(6) Fukutani, T.; Hirano, K.; Satoh, T.; Miura, M. J. Org. Chem. 2011,
76, 2867.
(7) Morimoto, K.; Hirano, K.; Satoh, T.; Miura, M. Org. Lett. 2010,
12, 2068.
(8) Iitsuka, T.; Hirano, K.; Satoh, T.; Miura, M. Chem.Eur. J. 2014,
20, 385.
(9) Pham, M. V.; Cramer, N. Angew. Chem., Int. Ed. 2014, 53, 3484.
(10) (a) Huang, J.-R.; Zhang, Q.-R.; Qu, C.-H.; Sun, X.-H.; Dong, L.;
Chen, Y.-C. Org. Lett. 2013, 15, 1878. (b) Huang, J.-R.; Dong, L.; Han,
B.; Peng, C.; Chen, Y.-C. Chem.Eur. J. 2012, 18, 8896.
(11) Tan, X.; Liu, B.; Li, X.; Li, B.; Xu, S.; Song, H.; Wang, B. J. Am.
Chem. Soc. 2012, 134, 16163.
(12) Zheng, L.; Hua, R. J. Org. Chem. 2014, 79, 3930.
(13) Jayakumar, J.; Parthasarathy, K.; Chen, Y. H.; Lee, T. H.;
Chuang, S. C.; Cheng, C. H. Angew. Chem., Int. Ed. 2014, 53, 9889.
(14) Zhang, L.; Zheng, L.; Guo, B.; Hua, R. J. Org. Chem. 2014, 79,
11541.
(15) (a) Song, G.; Chen, D.; Pan, C.-L.; Crabtree, R. H.; Li, X. J. Org.
Chem. 2010, 75, 7487. (b) Song, G.; Gong, X.; Li, X. J. Org. Chem.
2011, 76, 7583. (c) Qi, Z.; Li, X. Angew. Chem., Int. Ed. 2013, 52, 8995.
(16) (a) Yu, S.; Li, X. Org. Lett. 2014, 16, 1220. (b) Kwak, J.; Ohk, Y.;
Jung, Y.; Chang, S. J. Am. Chem. Soc. 2012, 134, 17778. (c) Zucca, A.;
Cinellu, M. A.; Pinna, M. V.; Stoccoro, S.; Minghetti, G.; Manassero,
M.; Sansoni, M. Organometallics 2000, 19, 4295. (d) Minghetti, G.;
Stoccoro, S.; Cinellu, M. A.; Soro, B.; Zucca, A. Organometallics 2003,
22, 4770.
(17) Crystallographic data for compound 3ka′ has been deposited to
the Cambridge Crystallographic Data Centre as entry CCDC
1042680.
(18) (a) Muralirajan, K.; Cheng, C.-H. Chem.Eur. J. 2013, 19,
6198. (b) Jayakumar, J.; Parthasarathy, K.; Cheng, C.-H. Angew. Chem.,
Int. Ed. 2012, 51, 197. (c) Luo, C.-Z.; Gandeepan, P.; Jayakumar, J.;
Parthasarathy, K.; Chang, Y.-W.; Cheng, C.-H. Chem.Eur. J. 2013,
19, 14181. (d) Luo, C.-Z.; Gandeepan, P.; Cheng, C.-H. Chem.
Commun. 2013, 49, 8528.
(19) Zhao, D.; Wu, Q.; Huang, X.; Song, F.; Lv, T.; You, J. Chem.
Eur. J. 2013, 19, 6239.
(20) Zhang, G.; Yang, L.; Wang, Y.; Xie, Y.; Huang, H. J. Am. Chem.
Soc. 2013, 135, 8850.
(21) Mio, M. J.; Kopel, L. C.; Braun, J. B.; Gadzikwa, T. L.; Hull, K.
L.; Brisbois, R. G.; Markworth, C. J.; Grieco, P. A. Org. Lett. 2002, 4,
3199.
(22) Aginagalde, M.; Vara, Y.; Arrieta, A.; Zangi, R.; Cebolla, V. L.;
Delgado-Camón, A.; Cossío, F. P. J. Org. Chem. 2009, 75, 2776.
(23) Fujita, K.-i.; Takahashi, Y.; Owaki, M.; Yamamoto, K.;
Yamaguchi, R. Org. Lett. 2004, 6, 2785.

3479

DOI: 10.1021/acs.joc.5b00059
J. Org. Chem. 2015, 80, 3471−3479

